{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:36:28Z","timestamp":1770525388075,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10461-016-1299-8","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T13:53:58Z","timestamp":1454421238000},"page":"2644-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States"],"prefix":"10.1007","volume":"20","author":[{"given":"Ariane","family":"van der Straten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Panther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig J.","family":"Hoesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla J.","family":"Husnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalene","family":"Nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Soto-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,2]]},"reference":[{"issue":"7","key":"1299_CR1","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","volume":"26","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012;26(7):F13\u20139.","journal-title":"AIDS"},{"key":"1299_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-med-050911-163701","volume":"64","author":"J Baeten","year":"2013","unstructured":"Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annu Rev Med. 2013;64:219.","journal-title":"Annu Rev Med"},{"key":"1299_CR3","unstructured":"Hendrix CW, Andrade A, Kashuba A, et al. Tenofovir-Emtricitabine directly observed dosing: 100\u00a0% adherence concentrations (HPTN 066). Paper presented at: 21st Conference on Retorviruses and Opportunistic Infections. Boston; 2014."},{"key":"1299_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/COH.0b013e3283582d4a","volume":"7","author":"K Amico","year":"2012","unstructured":"Amico K. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness. Curr Opin HIV AIDS. 2012;7:542\u20138.","journal-title":"Curr Opin HIV AIDS"},{"issue":"2, Part 1","key":"1299_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","volume":"111","author":"MD Creinin","year":"2008","unstructured":"Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Gynecol Oncol. 2008;111(2, Part 1):267\u201377. doi:\n                    10.1097\/01.AOG.0000298338.58511.d1\n                    \n                  .","journal-title":"Gynecol Oncol"},{"key":"1299_CR6","unstructured":"UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: Joint United Nations Programme on HIV\/AIDS (UNAIDS). 2013."},{"issue":"3","key":"1299_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","volume":"1","author":"D Friend","year":"2011","unstructured":"Friend D. Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections. Drug Deliv Transl Res. 2011;1(3):185\u201393.","journal-title":"Drug Deliv Transl Res"},{"key":"1299_CR8","unstructured":"Woodsong C, Montgomery E, Masenga G, et al. Safety and acceptability of vaginal ring as microbicide delivery method in African women. Paper presented at Microbicides, Pittsburg; Accessed 23\u201326 May 2010."},{"key":"1299_CR9","unstructured":"van der Straten A, Woodsong C, ET M, Nel A. High adherence and acceptability of a monthly Dapivirine vaginal ring for HIV prevention in Africa. Paper presented at International Microbicides Conference, Sydney, Australia; 2012."},{"key":"1299_CR10","unstructured":"Nel A, Kamupira M, Woodsong C, van der Straten A, ET M, van Niekerk N. Safety, acceptability, and pharmacokinetics assessment (adherence of monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV prevention. Paper presented at Conference on Retrovirus and Opportunistic Infections, Seattle; 2012."},{"key":"1299_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10461-012-0248-4","volume":"16","author":"E Montgomery","year":"2012","unstructured":"Montgomery E, van der Straten A, Cheng H, et al. Vaginal ring adherence in Sub-Saharan Africa: expulsion, removal, and perfect use. AIDS Behav. 2012;16:1787\u201398.","journal-title":"AIDS Behav"},{"key":"1299_CR12","unstructured":"Phase III trial of dapivirine ring begins in Africa: ASPIRE testing new HIV prevention approach for women. \n                    http:\/\/www.mtnstopshiv.org\/node\/4546\n                    \n                  : Microbicides Trial Network; 2012."},{"key":"1299_CR13","unstructured":"First efficacy trial of a microbicide ring to prevent HIV is underway: the ring study to assess IPM\u2019s monthly ARV ring for women. \n                    http:\/\/www.ipmglobal.org\/publications\/first-efficacy-trial-microbicide-ring-prevent-hiv-underway\n                    \n                  : International Partnership for Microbicides, Inc.; 2012."},{"key":"1299_CR14","unstructured":"NuvaRing. Registration In South Africa, MSD pharmaceuticals, 2012."},{"issue":"3","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","volume":"67","author":"A Novak","year":"2003","unstructured":"Novak A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception. 2003;67(3):187\u201394.","journal-title":"Contraception"},{"issue":"5","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.contraception.2010.04.012","volume":"82","author":"V Brache","year":"2010","unstructured":"Brache V, Faundes A. Contraceptive vaginal rings: a review. Contraception. 2010;82(5):418\u201327.","journal-title":"Contraception"},{"issue":"3","key":"1299_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","volume":"87","author":"V Brache","year":"2013","unstructured":"Brache V, Pay\u00e1n LJ, Faundes A. Current status of contraceptive vaginal rings. Contraception. 2013;87(3):264\u201372.","journal-title":"Contraception"},{"issue":"6","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jpag.2007.06.001","volume":"20","author":"FH Stewart","year":"2007","unstructured":"Stewart FH, Brown BA, Raine TR, Weitz TA, Harper CC. Adolescent and young women\u2019s experience with the vaginal ring and oral contraceptive pills. J Pediatr Adolesc Gynecol. 2007;20(6):345\u201351.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"1299_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/QAI.0000000000000702","volume":"70","author":"B Chen","year":"2015","unstructured":"Chen B, Panther L, Marzinke MA, et al. Phase 1 Safety, pharmacokinetics, and pharmacodynamics of dapivirine and Maraviroc vaginal rings: a double-blind randomized trial. J Acquir Immune Defic Syndr. 2015;70:242\u201349.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1299_CR20","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s10461-012-0215-0","volume":"16","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Montgomery E, Cheng H, et al. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women. AIDS Behav. 2012;16:1775\u201386.","journal-title":"AIDS Behav"},{"issue":"5","key":"1299_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s10461-013-0652-4","volume":"18","author":"JJ van den Berg","year":"2014","unstructured":"van den Berg JJ, Rosen RK, Bregman DE, et al. \u201cSet it and forget it\u201d: women\u2019s perceptions and opinions of long-acting topical vaginal gels. AIDS Behav. 2014;18(5):862\u201370.","journal-title":"AIDS Behav"},{"issue":"1","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2147\/IJWH.S36282","volume":"4","author":"R Malcolm","year":"2012","unstructured":"Malcolm R, Fetherston S, McCoy C, Boyd P, Major I. Vaginal rings for delivery of HIV microbicides. Int J Women\u2019s Health. 2012;4(1):595\u2013605.","journal-title":"Int J Women\u2019s Health"},{"key":"1299_CR23","doi-asserted-by":"crossref","unstructured":"Minnis AM, van der Straten A, Salee P, Hendrix CW. Pre-exposure prophylaxis adherence measured by plasma drug level in MTN-001: comparison between vaginal gel and oral tablets in two geographic regions. AIDS Behav. 2015.","DOI":"10.1007\/s10461-015-1081-3"},{"issue":"1","key":"1299_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jadohealth.2007.12.007","volume":"43","author":"LB Epstein","year":"2008","unstructured":"Epstein LB, Sokal-Gutierrez K, Ivey SL, Raine T, Auerswald C. Adolescent experiences with the vaginal ring. J Adolesc Health. 2008;43(1):64\u201370.","journal-title":"J Adolesc Health"},{"issue":"3","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1363\/3814806","volume":"38","author":"SS Witte","year":"2006","unstructured":"Witte SS, El-Bassel N, Gilbert L, Wu E, Chang M, Hill J. Promoting female condom use to heterosexual couples: findings from a randomized clinical trial. Perspect Sex Reprod Health. 2006;38(3):148\u201354.","journal-title":"Perspect Sex Reprod Health"},{"issue":"6","key":"1299_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/13625180903215430","volume":"14","author":"E Montgomery","year":"2009","unstructured":"Montgomery E, Blanchard K, Cheng H, et al. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. Eur J Contracept Reprod Health Care. 2009;14(6):410\u20139.","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-016-1299-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1299-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-016-1299-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T11:56:46Z","timestamp":1589716606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-016-1299-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s10461-016-1299-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]},"assertion":[{"value":"2 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}